Lundbeck
HLUN-B.CO
#2403
Rank
โ‚น510.84 B
Marketcap
โ‚น533.85
Share price
-0.36%
Change (1 day)
30.23%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): โ‚น29.01

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is โ‚น29.86. In 2022 the company made an earnings per share (EPS) of โ‚น22.71 a decrease over its 2021 EPS that were of โ‚น51.00.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น29.0127.75%
2022โ‚น22.71-55.47%
2021โ‚น51.00-51.83%
2020โ‚น105.87-28.01%
2019โ‚น147.06-44.08%
2018โ‚น262.9851.94%
2017โ‚น173.08126.64%
2016โ‚น76.37-120.84%
2015-โ‚น366.465622.18%
2014-โ‚น6.40-110.03%
2013โ‚น63.83-28.08%
2012โ‚น88.75-52.1%
2011โ‚น185.27-1.31%
2010โ‚น187.7315.61%
2009โ‚น162.38